All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99


Endothelial Nitric Oxide Synthase (eNOS) Glu298Asp Gene Polymorphism (G894T) as a Risk Factor for Type 2 Diabetes Mellitus in the Tunisian Population

DOI: 10.4236/oalib.1104171, PP. 1-9

Subject Areas: Diabetes & Endocrinology

Keywords: T2DM, eNOS, The G894T Polymorphism of eNOS Gene

Full-Text   Cite this paper   Add to My Lib


Introduction: Diabetes mellitus is a chronic disease whose global expansion gives it the characteristics of a pandemic. Diabetes risk factors are well known. In this work we proposed to study the role of genetic polymorphism of the eNOS G894T gene in the development of diabetes on the one hand and of these degenerative complications other. Methods: We conducted a prospective case-control study in which we included 200 subjects divided into 100 patients with type 2 diabetes and 100 controls in apparent good health. For each patient and control we measured lipid parameters, CRP-us and sought the G894T polymorphism of eNOS gene by PCR-RFLP. Results: The analysis of our results shows a statistically significant elevated TG values (p < 10﹣3), Lp (a) (p < 10﹣3), and CRP-us (p < 10﹣3) in type 2 diabetes compared with controls. The mutated genotypes of GT eNOS gene was significantly more frequent in diabetic patients. In our series, we did not notice any significant difference in genotype or allele frequency between diabetics with and without degenerative complications. Conclusion: The G894T polymorphism of eNOS gene appears to be a risk factor of T2DM. His role in the development of degenerative complications remains proved.

Cite this paper

Sendesni, R. , Grira, N. , Lamine, O. , Aboulkassem, S. , Ayoub, M. , Stambouli, N. , Haroun, O. , Mazigh, C. and Aouni, Z. (2018). Endothelial Nitric Oxide Synthase (eNOS) Glu298Asp Gene Polymorphism (G894T) as a Risk Factor for Type 2 Diabetes Mellitus in the Tunisian Population. Open Access Library Journal, 5, e4171. doi:


[1]  Moncada, S. and Higgs, E.A. (2006) The Discovery of Nitric Oxide and Its Role in Vascular Biology. British Journal of Pharmacology, 147, 193-201.
[2]  Park, K.W., You, K.H., Oh, S., Chae, I.H., Kim, H.S., Oh, B.H., et al. (2004) Association of Endothelial Constitutive Nitric Oxide Synthase Gene Polymorphism with Acute Coronary Syndrome in Koreans. Heart, 90, 282-285.
[3]  Ignarro, L.J., Cirino, G., Casini, A., et al. (1999) Nitric Oxide as a Signaling Molecule in the Vascular System: An Overview. Journal of Cardiovascular Pharmacology, 34, 879-886.
[4]  Creager, M.A., Luscher, T.F., Cosentino, F. and Beckman, J.A. (2003) Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I. Circulation, 108, 1527-1532.
[5]  Markus, H.S., Ruigrok, Y., Ali, N., et al. (1998) Endothelial Nitric Oxide Synthase exon 7 Polymorphism, Ischemic Cerebrovascular Disease, and Carotid Atheroma. Stroke, 29, 1908-1911.
[6]  Azmy, R., Dawood, A., Kilany, A., El-Ghobashy, Y., Ellakwa, A.F. and El-Daly, M. (2012) Association Analysis of Genetic Variations of eNOS and α2β1 Integrin Genes with Type 2 Diabetic Retinopathy. The Application of Clinical Genetics, 5, 55-65.
[7]  Lembo, G., De Luca, N., Battagli, C., et al. (2001) A Common Variant of Endothelial Nitric Oxide Synthase (Glu298Asp) Is an Independent Risk Factor for Carotid Athero-sclerosis. Stroke, 32, 735-740.
[8]  Karvonen, J., Kauma, H., Kervinen, K., et al. (2002) Endothelial Nitric Oxide Synthase Gene Glu298Asp Polymorphism and Blood Pressure, Left Ventricular Mass and Carotid Artery Atherosclerosis in a Population-Based Cohort. Journal of Internal Medicine, 251, 102-110.
[9]  Forstermann, U. (2006) Janus-Faced Role of Endothelial NO Synthase in Vascular Disease: Uncoupling of Oxygen Reduction from NO Synthesis and Its Pharmacological Reversal. Biological Chemistry, 387, 1521-1533.
[10]  Tai, S.C., Robb, G.B. and Marsden, P.A. (2004) Endothelial Nitric Oxide Synthase: A New Paradigm for Gene Regulation in the Injured Blood Vessel. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 405-412.
[11]  Leighton, F., Miranda-Rottmann, S. and Urquiaga, I. (2006) A Central Role of eNOS in the Protective Effect of Wine Against Metabolic Syndrome. Cell Biochemistry and Function, 24, 291-298.
[12]  Evans, J.L., Goldfine, I.D. and Maddux, B.A. (2002) Oxidative Stress and Stress Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes. Endocrine Reviews, 23, 599-622.
[13]  Dellamea, S.B., Ferreira Pinto, C.L., Leitao, B.C., Santos, G.K. and Santos Canani, H.L. (2014) Endothelial Nitric Oxide Synthase Gene Polymorphisms and Risk of Diabetic Nephropathy: A Systematic Review and Meta-Analysis. BMC Medical Genetics, 15-19.
[14]  Veldman, B.A., Spiering, W., Doevendans, P.A., Vervoort, G., Kroon, A.A., et al. (2002) The Glu298Asp Polymorphism of the NOS 3 Gene as a Determinant of the Baseline Production of Nitric Oxide. Journal of Hypertension, 2023-2027.
[15]  Angeline, T., Krithiga, H.R., Isabel, W., Asirvatham, A.J. and Poornima, A. (2011) Endothelial Nitric Oxide Synthase Gene Polymorphism (G894T) and Diabetes Mellitus (Type II) among South Indians. Oxidative Medicine and Cellular Longevity, 462-467.
[16]  Nishevitha, N.S., Angeline, T. and Jeyaraj, N. (2009) Endothelial Nitric Oxide Synthase (eNOS) Glu298àAsp Polymorphism (G894T) among South Indians. Indian Journal of Medical Research, 129, 68-71.
[17]  Monti, L.D., Barlassina, C., Citterio, L., et al. (2003) Endothelial Nitric Oxide Synthase Polymorphisms Are Associated with Type 2 Diabetes and the Insulin Resistance Syndrome. Diabetes, 2003, 1270-1275.
[18]  Bressler, J., Pankow, J.S., Coresh, J. and Boerwinkle, E. (2013) Interaction between the NOS3 Gene and Obesity as a Determinant of Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities Study. PLoS ONE, 8, e79466.
[19]  Cheema, B.S., Kohli, H.S., Sharma, R., Bhansali, A. and Khullar, M. (2012) Endothelial Nitric Oxide Synthase Gene Polymorphism and Type 2 Diabetic Retinopathy among Asian Indians. Acta Diabetologica, 49, 481-488.
[20]  Shin, Y., Baek, S.H., Chang, K.Y., Park, C.W., Yang, C.W., et al. (2004) Relations between eNOS Glu298Asp Polymorphism and Progression of Diabetic Nephropathy. Diabetes Research and Clinical Practice, 65, 257-265.
[21]  Zhao, C.X., Xu, X., Cuil, Y., Wang, P., Wei, X., Yang, S., Edin, M.L., Zeldin, D.C. and Wang, D.W. (2008) Increased Endothelial Nitric-Oxide Synthase Expression Reduces Hypertension and Hyperinsulinemia in Fructose-Treated Rats. JPET, 328, 610-620.
[22]  Vecoli, C., Novelli, M., Pippa, A., Giacopelli, D., Beffy, P., Masiello, P., L’Abbate, A. and Neglia, D. (2014) Partial Deletion of eNOS Gene Causes Hyperinsulinemic State, Unbalance of Cardiac Insulin Signaling Pathways and Coronary Dysfunction Independently of High Fat Diet. PLoS ONE, 8, e104156.
[23]  Sally, M., Vijay, S. and McNeill (2009) Insulin Resistance and Endothelial Dysfunction: Are Epoxyeicosatrienoic Acids the Link? Experimental & Clinical Cardiology, 14, 41-50.
[24]  Tabit, C.E., Shenouda, S.M., Holbrook, M., Fetterman, J.L., Kiani, S., Frame, A.A., Kluge, M.A., Held, A., Dohadwala, M., Gokce, N., Farb, M., Rosenzweig, J., Ruderman, N., Vita, J.A. and Hamburg, N.M. (2013) Protein Kinase-C Beta Contributes to Impaired Endothelial Insulin Signaling in Humans with Diabetes Mellitus. Circulation, 127, 86-95.


comments powered by Disqus

Contact Us


微信:OALib Journal